Teradyne Director Marilyn Matz Files Form 144 Notice to Sell $270K in Common Stock Under 10b5-1 Plan
TERADYNE, INC
Subscribe to track TER
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice: Teradyne, Inc. (NASDAQ: TER) Insider: Marilyn Matz (Director) Action: Notice of Proposed Sale Shares: 800 common shares (~$270,264.00) Approx. Sale Date: 2026-09-15 Trading Plan: Rule 10b5-1 adopted on 02/13/2026 Significance: Low
Comprehensive Analysis
Executive Summary
On September 15, 2026, Marilyn Matz, a Director of Teradyne, Inc. (TER), filed a Form 144 notice of proposed sale covering 800 shares of common stock with an aggregate market value of approximately $270,264.00 (implying an average price of ~$337.83 per share).
Key Transaction Highlights
- Filer: Marilyn Matz, Director
- Broker: Fidelity Brokerage Services LLC
- Securities Offered: 800 Common Shares
- Estimated Value: $270,264.00
- Date of Acquisition / Nature: Acquired on May 7, 2021, via Restricted Stock Vesting as equity compensation from the Issuer.
- Pre-Arranged Trading Plan: The sale is executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2026.
Prior 3-Month Activity
Within the past three months, the insider reported the following completed sales:
- 06/15/2026: 1,200 shares sold for gross proceeds of $507,636.00
- 07/15/2026: 1,200 shares sold for gross proceeds of $427,572.00
- 08/17/2026: 1,200 shares sold for gross proceeds of $510,000.00
Market Impact & Significance
The transaction represents an immaterial fraction of Teradyne's 156.34 million shares outstanding. Given the standard size and execution under a pre-established Rule 10b5-1 trading plan, the market impact is considered Low and reflects routine scheduled insider diversification.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
